Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 22,859,000 | 19,960,000 | 18,790,000 | 18,380,000 | 17,443,951 |
| Cost of Goods | 4,500,000 | 4,426,000 | 4,581,000 | 4,508,000 | 4,639,393 |
| Gross Profit | 18,359,000 | 15,534,000 | 14,209,000 | 13,872,000 | 12,804,558 |
| Operating Expenses | 10,822,000 | 12,123,000 | 8,545,000 | 8,055,000 | 8,511,326 |
| Operating Income | 7,537,000 | 3,411,000 | 5,664,000 | 5,817,000 | 4,293,232 |
| Interest Expense | 719,000 | 429,000 | 299,000 | 104,000 | N/A |
| Other Income | -173,000 | -613,000 | -33,000 | 12,000 | -624,705 |
| Pre-tax Income | 6,645,000 | 2,369,000 | 5,332,000 | 5,725,000 | 3,668,527 |
| Income Tax | 1,501,000 | 595,000 | 1,204,000 | 450,000 | 235,399 |
| Net Income Continuous | 5,144,000 | 1,774,000 | 4,128,000 | 5,275,000 | 3,433,128 |
| Net Income | $5,144,000 | $1,774,000 | $4,128,000 | $5,275,000 | $3,433,128 |
| EPS Basic Total Ops | 0.33 | 0.12 | 0.27 | 0.35 | 0.22 |
| EPS Basic Continuous Ops | 0.33 | 0.12 | 0.27 | 0.35 | N/A |
| EPS Diluted Total Ops | 0.33 | 0.12 | 0.27 | 0.35 | 0.22 |
| EPS Diluted Continuous Ops | 0.33 | 0.12 | 0.27 | 0.35 | N/A |
| EBITDA(a) | $8,200,000 | $3,584,000 | $6,528,000 | $6,979,000 | $5,565,426 |